Wellnara post-marketing surveillance in Japan (WELLNARA)
This study is a regulatory post marketing surveillance in Japan, and it is a local prospective and observational study of patients who have received Wellnara for postmenopausal osteoporosis. The objective of this study is to assess safety and efficacy of using Wellnara in clinical practice. A total 400 patients will be recruited and followed 3 years since starting Wellnara administration.
- Patients who received Wellnara for postmenopausal osteoporosis
- Patients who are contraindicated based on the product label
Many Locations, Japan
E-mail: [email protected]
Phone: Not Available
Drug use investigation of Wellnara Tablet